Drug Target Review: Could a nasal spray prevent COVID-19?
A UC study shows that a lipid might prevent infection and could potentially be easily administered
According to a study led by UC researchers, the lipid sphingosine may have the ability to inhibit SARS-CoV-2 infection and could potentially be delivered in a nasal spray to prevent COVID-19 infections.
Researchers, led by a visiting professor in the UC Department of Surgery Erich Gulbins, MD, have examined pre-existing research into bacterial respiratory tract infections and applied the findings to COVID-19, with some success. According to the scientists, a sphingosine nasal spray could potentially prevent or treat SARS-CoV-2 infections.
“We investigated whether a specific lipid [sphingosine] is able to interfere with the binding of SARS-CoV-2 to human epithelial cells,” said Gulbins, corresponding author on the study, published in the Journal of Biological Chemistry.
Featured photo of the lipid sphingosine courtesy of Jynto.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
UC Board of Trustees approves $12 million for building design phase for new welcome gateway
March 13, 2026
The UC Board of Trustees approved $12 million at its Feb. 24 meeting for the design phase of a new Welcome Gateway Building for Uptown campus.
Dual-arm robot stabilizes satellite for repairs in space
March 13, 2026
Interesting Engineering highlights an aerospace engineering research project examining novel ways to keep repair robots oriented in space.
Scientists discover how snakes stand upright without limbs
March 12, 2026
Earth.com highlights a study co-authored by UC Professor Bruce Jayne, an expert in snake locomotion, about how snakes stand upright without arms or legs.